title: Dysplastic neocortex and subcortical heterotopias in methylazoxymethanol-treated rats: an intracellular study of identified pyramidal neurones.
abstract: Intracellular recordings were obtained using biocytin-filled electrodes from 78 neurones located in both dysplastic neocortex and subcortical heterotopic aggregates in a model of neuronal migration disorder induced in rats by means of a double methylazoxymethanol injection given on embryonic day 15. Both regular spiking and intrinsically bursting pyramidal neurones were found in all of the examined structures and were synaptically activated by subcortical stimulation. In a neuronal subpopulation (22%) located in the neocortex as well as in the subcortical heterotopic aggregates, the injection of depolarising current pulses elicited aberrant firing patterns, consisting of repetitive bursts of APs that gradually increased in duration and eventually merged in a long-lasting discharge. The gradual development of this 'excessive' bursting behaviour suggests a progressive run-down of the slow components of the hyperpolarising afterpotential.
authors.affiliation: Istituto Nazionale Neurologico C. Besta Laboratorio di Neurofisiologico, Sperimentale, Milan, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Sancini
authors.forename: S
authors.initials: S
authors.lastname: Franceschetti
authors.forename: G
authors.initials: G
authors.lastname: Battaglia
authors.forename: C
authors.initials: C
authors.lastname: Colacitti
authors.forename: M
authors.initials: M
authors.lastname: Di Luca
authors.forename: R
authors.initials: R
authors.lastname: Spreafico
authors.forename: G
authors.initials: G
authors.lastname: Avanzini
mesh_terms: D000818:Animals; D002465:Cell Movement / Q000187:drug effects; D002552:Cerebral Ventricles / Q000187:drug effects / Q000473:pathology / Q000502:physiology; D002828:Choristoma / Q000503:physiopathology*; D046508:Culture Techniques; D004334:Drug Administration Schedule; D004558:Electric Stimulation; D004622:Embryo, Mammalian / Q000187:drug effects; D005071:Evoked Potentials / Q000187:drug effects / Q000502:physiology; D005260:Female; D006624:Hippocampus / Q000187:drug effects / Q000473:pathology / Q000502:physiology; D007274:Injections, Intraperitoneal; D007424:Intracellular Fluid / Q000502:physiology*; D018811:Maternal Exposure; D008431:Maternal-Fetal Exchange; D008564:Membrane Potentials / Q000502:physiology; D008746:Methylazoxymethanol Acetate / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D008839:Microelectrodes; D019579:Neocortex / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D009474:Neurons / Q000145:classification / Q000187:drug effects / Q000502:physiology; D011247:Pregnancy; D017966:Pyramidal Cells / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D051381:Rats; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology; D013997:Time Factors
chemical_list: D008746:Methylazoxymethanol Acetate; C030667:methylazoxymethanol